Skip to main content
PRTA logo
PRTA
(NASDAQ)
Prothena Corporation plc
$9.86-- (--)
Loading... - Market loading

Prothena Corporation (PRTA) Stock Price & Financial Analysis

Prothena Corporation Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$9.51 - $10.08
52-Week High$12.20
52-Week Low$4.32
Open$9.75
Volume848.82K
Average Volume (3M)848.82K
Market Cap530.75M
Shares Outstanding53.83M
Price to Sales (P/S)55.75
Price to Book (P/B)1.92
EV/EBITDA-1.39
Revenue (TTM)9.68M
Net Income (TTM)-244.09M
Free Cash Flow (TTM)-167.57M
EPS (TTM)$-4.53
Profit Margin-2520.57%
Operating Margin-1905.82%
Return on Equity (ROE)-87.03%
Debt to Equity0.05
50-Day MA$9.19
200-Day MA$8.86
52-Week Change-14.57%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Prothena Corporation

What is the current stock price for PRTA?

As of the latest trading session, PRTA stock trades at $9.86. The 52-week range is $4.32–$12.20, with a day range of $9.51–$10.08.

What is the P/E ratio for PRTA?

The P/E ratio (Price-to-Earnings) for PRTA is shown in the Key Statistics section. This valuation metric helps compare Prothena Corporation plc to industry peers.

Does PRTA pay dividends?

Prothena Corporation does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for PRTA?

Based on 1 analyst, the consensus for PRTA is Hold. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of PRTA?

Prothena Corporation's market capitalization is $530.8M, classifying it as a small-cap company. Prothena Corporation operates in the Healthcare sector within the Biotechnology industry.